https://ijrdpl.com/index.php/ijrdpl/issue/feed 2024-09-23T10:44:02+00:00 Managing Editor editor@ijrdpl.com Open Journal Systems <p><img src="https://ijrdpl.com/public/site/images/admin/800x414.jpg" alt="" width="400" height="207" /></p> <ol> <li><strong>Journal Title: </strong>International Journal of Research and Development in Pharmacy &amp; Life Sciences (IJRDPL)</li> <li><strong>Discipline, Focus &amp; Scope: </strong>Pharmaceutical Sciences, Medical Sciences &amp; Life Sciences</li> <li><strong>Publisher: </strong>Society for research and Development in Education</li> <li><strong>Country: </strong>India</li> <li><strong>Language: </strong>English</li> <li><strong>Publishing Frequency: </strong>Bi-monthly</li> <li><strong>Current Status:</strong>Online &amp; Print</li> <li><strong>e-ISSN: </strong>2278-0238<strong>P-ISSN:</strong> 2393-932X</li> <li><strong>Membership</strong>: International Committee of Medical Journal Editors (<a href="http://www.icmje.org/journals-following-the-icmje-recommendations/#I">ICMJE</a>)</li> <li><strong>Year of Start</strong>: 2012</li> <li><strong>CODEN (CAS-USA):</strong><strong><a href="https://cassi.cas.org/publication.jsp?P=LglBQf5Q2NQyz133K_ll3zLPXfcr-WXfViyskcpOmfA3O7R7eJ0GCDLPXfcr-WXfimSBIkq8XcUjhmk0WtYxmzLPXfcr-WXf4FxmOz2-BU_qe4fNZCk9lw">IJRDA9</a></strong></li> </ol> <p style="text-align: justify; font-size: 16px;"><strong>Email:</strong>editor@ijrdpl.com</p> <p style="text-align: justify; font-size: 16px;"><strong>Website:</strong> <a href="https://www.ijrdpl.com/">https://www.ijrdpl.com/</a></p> <p style="text-align: justify; font-size: 16px;">International Journal of Research and Development in Pharmacy &amp; Life Sciences (IJRDPL) is an official publication of SRDE (Society for research and Development in Education). It is an international peer-reviewed, open access, multidisciplinary journal, scheduled to appear bi-monthly and with the aim to serve as a mean for scientific information exchange and understandings at international pharmaceutical and life sciences forum.</p> <p style="text-align: justify; font-size: 16px;">International Journal of Research and Development in Pharmacy &amp; Life Sciences (IJRDPL) publishes original research articles; review articles; short communications; case reports; letters to the editors and rapid communications in all areas of Pharmaceutical and Basic Life Sciences.</p> <p style="text-align: justify; font-size: 16px;">“We support HIFA (Healthcare Information for All). We believe that every person and every health worker should have access to the health information they need to protect their own health and the health of others. We encourage you to join HIFA here: <a href="http://jddtonline.info/index.php/jddt/manager/setup/www.hifavoices.org" target="_blank" rel="noopener">www.hifa.org</a>“</p> <p>^{<img src="https://ubipayroll.com/IJRDPL/public/site/images/admin/2020-06-04-1832.png" alt="" width="111" height="114" />}</p> https://ijrdpl.com/index.php/ijrdpl/article/view/576 2024-09-23T10:38:31+00:00 Dr. S. L. Nirala editor@ijrdpl.com

<p><strong>ABSTRACT:</strong>&nbsp;</p> <p><strong>Introduction</strong>: Necrotizing fasciitis is a rare disease potentially life-threatening infection of fascia, subcutaneous tissue with occasionally muscular involvement. Necrotizing Fasciitis is a surgical emergency with high morbidity and mortality (carries a mortality of 10 to 25%).</p> <p><strong>Aims</strong>: Ais of the study, is to compare necrotizing fasciitis in diabetic and non-diabetic patients concerning age, sex, and duration of symptoms, site of involvement, causative organism, duration of hospital stay, and its outcome.</p> <p><strong>Materials and methods</strong>: In this study mean age was 54.81 years for diabetics and 44.06 years for non-diabetics, which implies Necrotizing Fasciitis is more common in middle-aged persons. This is a prospective study in Bhim Rao Ambedkar Hospital in Raipur Department of General Surgery. &nbsp;</p> <p><strong>Result</strong>: In both the group most common micro-organisms found in culture was <em>Staphylococcus</em>&nbsp;(43% in Diabetics and 45% in Non-Diabetics). The second most common micro-organism was <em>Streptococcus</em>&nbsp;(39% in Diabetics and 35% in Non-Diabetics). Other significant micro-organisms found were Klubsella Pneumococcus and polymicrobial. P Value 0.410 &gt; 0.05 There is no statically significant; there is no difference in micro-organism culture between Diabetics and Non- Diabetics. Trauma was the most common predisposing cause in both groups (55.8% in diabetes and 62.8% in non-diabetes.</p> <p><strong>Conclusion</strong>: In conclusion, the study reveals several key insights into necrotizing fasciitis, highlighting significant differences and similarities between diabetic and non-diabetic patients. Diabetic patients, typically over 60 years old, and non-diabetic patients, generally under 40 years old, both show a higher prevalence of necrotizing fasciitis among males, with trauma identified as the primary precipitating factor in both groups. <em>Staphylococcus</em>&nbsp;and <em>Streptococcus</em>&nbsp;were the predominant causative organisms in both categories.</p> <p>&nbsp;</p>

2024-09-23T00:00:00+00:00 Copyright (c) 2024 Dr. S. L. Nirala